SynthesisDrug design, development and therapy2018

Comparisons of therapeutic efficacy and safety of ipilimumab plus GM-CSF versus ipilimumab alone in patients with cancer: a meta-analysis of outcomes.

Peng Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.